Compare Novo Nordisk A/S (NVO) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Tractor Supply Co — how do they compare? Novo Nordisk A/S trades at $44.72 (market cap $200.69B), while Tractor Supply Co trades at $33.99 (market cap $18.39B). The key difference: Novo Nordisk A/S is far larger — about 10.9× Tractor Supply Co's market cap, and Novo Nordisk A/S pays the higher dividend (3.98%). Which is the better fit depends on your goals.
| NVO | TSCO | |
|---|---|---|
Market Cap | $200.69B | $18.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $63.98 | $60.61 |
52-Week Low | $35.29 | $29.14 |
Enterprise Value | $215.49B | $24.70B |
Dividend Yield | 3.98% | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $45.16, down 3.09% today, with bearish technical signals but strong fundamentals. The stock shows robust profitability with 35.35% net margin and 59.82% ROE, supported by consistent earnings beats. Recent developments include positive pediatric obesity trial results for semaglutide and Wegovy pill launch in Germany. Cash flow remains healthy with $10.81B net inflow in 2025, though 2026 projections show a decline.
NVO presents a mixed outlook with strong fundamental metrics offset by technical weakness and competitive pressures. Investment opportunity lies in the expanding GLP-1 market and pipeline developments, while risks include market share loss to Eli Lilly and failed cardiovascular drug trials. Analyst consensus leans bullish with 57.9% buy ratings, but recent prescription slowdown concerns warrant caution.
Tractor Supply Company (TSCO) trades at $35.29, up 0.86% on the day, with a bullish technical signal from moving averages. The stock is supported by strong profitability, including a 39.51% ROE and 6.42% net income margin, though recent quarterly EPS results have missed expectations. Revenue growth remains steady, reaching $15.52B in 2025, while analyst consensus is a Buy with a $36.29 price target. Recent corporate developments include a dividend payment and participation in industry conferences.
The outlook for TSCO is cautiously optimistic, with upside potential near the consensus target, but risks include competitive pressures and cyclical sales headwinds. Investment appeal hinges on execution of strategic initiatives in pet care and logistics, while monitoring margin trends and same-store sales performance is critical for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
